BioSpace News Archive

Feb. 18, 2020 14:03 UTC DENVER--( BUSINESS WIRE )-- ClinOne announces today its strategic collaboration with BioIntelliSense to combine continuous health monitoring and clinical intelligence with the ClinOne ClinTrialConnect™ patient portal platform. The addition of the FDA-cleared BioSticker™ single-use device provides an effortless trial participant experience enabling 30-days of continuous vital sign monitoring. “With BioIntelliSense, we will be able to capture a wide array o

Newton Dentistry is one of a handful of dental offices in the state of Massachusetts to offer comprehensive dental implants in one location.

Breakthrough Technology Enables Super-Fast Electrical Mapping and Re-Mapping of the Entire Heart Chamber - Leading to Rapid, Efficient and Individualized Ablation Strategies

FARMINGDALE, N.Y., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that it will be participating in the 40 th Annual Cowen Healthcare Conference taking place on Monday, March 2 nd at the Boston Marriott Copley Place hotel in Boston. Misonix President and Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Mi

Feb. 18, 2020 15:33 UTC IRVING, Texas--( BUSINESS WIRE )-- Acentrus Specialty™ , an Integrated Care Network and health system solution for specialty pharmacy, is vital to health systems to help them keep their patients inside the medical home. The Acentrus network includes 97 health system clients, the largest of its kind in the United States. Acentrus enhances specialty pharmacy product access and control for health systems and hospitals; participation is open to organizati

“Defensins are conceptually ideal for defense against different viral infections” WAKEFIELD, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, announced today the Company is exploring its lead defensin mimetic drug candidate, Brilacidin, as a potential novel coronavirus treatment. Over the last few weeks, the Company has received inquiries asking about Brilacidin’s potential to treat the Coronavirus g

Luminex Corporation announced that its board of directors declared a cash dividend for the first quarter of 2020 of $0.09 per share of common stock payable on April 9, 2020 to stockholders of record as of the close of business March 19, 2020.

VAXIL BIO LTD., an innovative immunotherapy biotech company specializing in cancer and infectious diseases, is pleased to provide further update to the Company’s press release dated February 13, 2020 on the possible identification of a corona virus vaccine candidate.

Main stage session highlights NASA plans to use advanced media technology to broadcast Artemis missions

Henry Schein, Inc. (Nasdaq:HSIC), today announced its lineup of new solutions and product offerings for the 2020 Chicago Midwinter (CMW) Dental Meeting, taking place February 20-22, 2020.